Miller Michael Patrick is a director of Puma Biotechnology Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
BioXcel Therapeutics, Inc.
11 Jun 24
4
PUMA BIOTECHNOLOGY, INC.
9 Nov 23
144
PUMA BIOTECHNOLOGY, INC.
7 Nov 23
4
BioXcel Therapeutics, Inc.
28 Jun 23
4
PUMA BIOTECHNOLOGY, INC.
15 Jun 23
144
PUMA BIOTECHNOLOGY, INC.
13 Jun 23
4
PUMA BIOTECHNOLOGY, INC.
10 Aug 22
4
BioXcel Therapeutics, Inc.
5 Jul 22
3
BioXcel Therapeutics, Inc.
5 Jul 22
4
PUMA BIOTECHNOLOGY, INC.
16 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Jun 24 | BTAI BioXcel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.44 | 17,000 | 24.48 k | 17,000 |
7 Nov 23 | PBYI Puma Biotechnology | Common Stock | Sell | Dispose S | No | No | 2.8321 | 25,000 | 70.80 k | 43,358 |
26 Jun 23 | BTAI BioXcel Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 17.52 | 17,000 | 297.84 k | 17,000 |
13 Jun 23 | PBYI Puma Biotechnology | Common Stock | Grant | Acquire A | No | No | 0 | 27,000 | 0.00 | 68,358 |
13 Jun 23 | PBYI Puma Biotechnology | Common Stock | Sell | Dispose S | No | Yes | 3.4541 | 13,500 | 46.63 k | 41,358 |